{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:14:51Z","timestamp":1792678491067,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.vaccine.2007.02.083","type":"journal-article","created":{"date-parts":[[2007,3,16]],"date-time":"2007-03-16T07:01:31Z","timestamp":1174028491000},"page":"4223-4234","source":"Crossref","is-referenced-by-count":138,"title":["Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: Double-blind randomised efficacy field trial"],"prefix":"10.1016","volume":"25","author":[{"given":"Jean-Loup","family":"Lemesre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Holzmuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel Bras","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Bourdoiseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Cavaleyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Papierok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib1","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/00034983.1986.11812021","article-title":"Leishmaniasis in Sardinia. I. Observations on a larval breeding site of Phlebotomus perniciosus, Phlebotomus perfiliewi perfiliewi and Sergentomyia minuta (Diptera: Psychodidae) in the canine leishmaniasis focus of Soleminis (Cagliari)","volume":"80","author":"Bettini","year":"1986","journal-title":"Ann Trop Med Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.083_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1993.48.1","article-title":"Studies on the control of visceral leishmaniasis: validation of the Falcon assay screening test-enzyme-linked immunosorbent assay (FAST-ELISA) for field diagnosis of canine visceral leishmaniasis","volume":"48","author":"Ashford","year":"1993","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.083_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4269\/ajtmh.1996.55.39","article-title":"A cross-sectional serodiagnostic survey of canine leishmaniasis due to Leishmania chagasi","volume":"55","author":"Paranhos-Silva","year":"1996","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4269\/ajtmh.1995.52.287","article-title":"Control of zoonotic visceral leishmaniasis: is it time to change strategies?","volume":"52","author":"Tesh","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"9330","key":"10.1016\/j.vaccine.2007.02.083_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0140-6736(02)09609-5","article-title":"Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial","volume":"360","author":"Gavgani","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.083_bib6","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/00034983.1992.11812717","article-title":"Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment","volume":"86","author":"Gramiccia","year":"1992","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.083_bib7","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/00034983.1988.11812290","article-title":"Epidemiological studies on American leishmaniasis in Ceara State, Brazil. Molecular characterization of the Leishmania isolates","volume":"82","author":"Vasconcelos","year":"1988","journal-title":"Ann Trop Med Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.083_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0035-9203(88)90511-1","article-title":"Studies on canine leishmaniasis control. 2. Effectiveness of control measures against canine leishmaniasis in the Isle of Elba, Italy","volume":"82","author":"Gradoni","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.083_bib9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.4269\/ajtmh.2001.65.510","article-title":"Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil","volume":"65","author":"Palatnik-de-Sousa","year":"2001","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.083_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1086\/516096","article-title":"Effect of eliminating seropositive canines on the transmission of visceral leishmaniasis in Brazil","volume":"25","author":"Dietze","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.083_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4269\/ajtmh.1998.59.53","article-title":"Studies on control of visceral leishmaniasis: impact of dog control on canine and human visceral leishmaniasis in Jacobina, Bahia, Brazil","volume":"59","author":"Ashford","year":"1998","journal-title":"Am J Trop Med Hyg"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.02.083_bib12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-4017(01)00486-1","article-title":"An update on antileishmanial vaccine candidates and prospects for a canine Leishmania vaccine","volume":"100","author":"Gradoni","year":"2001","journal-title":"Vet Parasitol"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2007.02.083_bib13","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int J Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib14","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J Med Res"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.083_bib15","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1365-3024.1989.tb00676.x","article-title":"Vaccination trial against canine visceral leishmaniasis","volume":"11","author":"Dunan","year":"1989","journal-title":"Parasite Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.083_bib16","first-page":"441","article-title":"Immune responses in vaccinated dogs with autoclaved Leishmania major promastigotes","volume":"30","author":"Lasri","year":"1999","journal-title":"Vet Res"},{"issue":"9\u201310","key":"10.1016\/j.vaccine.2007.02.083_bib17","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0264-410X(98)00338-7","article-title":"Evaluation of the stability and immunogenicity of autoclaved and nonautoclaved preparations of a vaccine against American tegumentary leishmaniasis","volume":"17","author":"De Luca","year":"1999","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.083_bib18","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ije\/15.4.572","article-title":"Controlled field trials of a vaccine against New World cutaneous leishmaniasis","volume":"15","author":"Antunes","year":"1986","journal-title":"Int J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.083_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0738-081X(96)00040-5","article-title":"Vaccine for prophylaxis and immunotherapy, Brazil","volume":"14","author":"Genaro","year":"1996","journal-title":"Clin Dermatol"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2007.02.083_bib20","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.02.083_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-2427(02)00315-X","article-title":"A Leishmania infantum multi-component antigenic protein mixed with live BCG confers protection to dogs experimentally infected with L. infantum","volume":"92","author":"Molano","year":"2003","journal-title":"Vet Immunol Immunopathol"},{"issue":"27\u201328","key":"10.1016\/j.vaccine.2007.02.083_bib22","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1016\/S0264-410X(02)00294-3","article-title":"Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN)","volume":"20","author":"Borja-Cabrera","year":"2002","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2007.02.083_bib23","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/j.vaccine.2005.05.011","article-title":"Leishmune vaccine blocks the transmission of canine visceral leishmaniasis: absence of Leishmania parasites in blood, skin and lymph nodes of vaccinated exposed dogs","volume":"23","author":"Nogueira","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.02.083_bib24","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.4049\/jimmunol.164.7.3741","volume":"164","author":"Prigione","year":"2000","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.083_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0304-4017(03)00044-X","article-title":"Immune responses against excreted\/secreted antigens of Toxoplasma gondii tachyzoites in the murine model","volume":"113","author":"Daryani","year":"2003","journal-title":"Vet Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib26","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.4049\/jimmunol.173.3.1966","article-title":"Characterization of a Mycobacterium tuberculosis peptide that is recognized by human CD4+ and CD8+ T cells in the context of multiple HLA alleles","volume":"173","author":"Shams","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2007.02.083_bib27","article-title":"Vaccination with the divergent portion of the protein histone H2B of Leishmania protects susceptible BALB\/c mice against a virulent challenge with Leishmania major","author":"Chenik","year":"2005","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2007.02.083_bib28","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1128\/IAI.66.7.3279-3289.1998","article-title":"Human and murine immune responses to a novel Leishmania major recombinant protein encoded by members of a multicopy gene family","volume":"66","author":"Webb","year":"1998","journal-title":"Infect Immun"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2007.02.083_bib29","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.vetimm.2005.03.001","article-title":"Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis","volume":"106","author":"Holzmuller","year":"2005","journal-title":"Vet Immunol Immunopathol"},{"issue":"22","key":"10.1016\/j.vaccine.2007.02.083_bib30","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1016\/j.vaccine.2004.11.061","article-title":"Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes","volume":"23","author":"Lemesre","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2007.02.083_bib31","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/IAI.72.10.5654-5661.2004","article-title":"Immunization with Leishmania major exogenous antigens protects susceptible BALB\/c mice against challenge infection with L. major","volume":"72","author":"Tonui","year":"2004","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.083_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.exppara.2004.11.008","article-title":"Leishmania infantum: soluble proteins released by the parasite exert differential effects on host immune response","volume":"109","author":"Rosa","year":"2005","journal-title":"Exp Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.083_bib33","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/JCM.44.4.1318-1322.2006","article-title":"Incidence and time course of Leishmania infantum infections examinated by parasitological, serologic, and nested-PCR techniques in a cohort of na\u00efve dogs exposed to three cosecutive transmission seasons","volume":"44","author":"Oliva","year":"2006","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.083_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4269\/ajtmh.1999.60.41","article-title":"Leishmania spp: completely defined medium without serum and macromolecules (CDM\/LP) for the continuous in vitro cultivation of infective promastigote forms","volume":"60","author":"Merlen","year":"1999","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2007.02.083_bib35","unstructured":"Lemesre JL, Methods for the culture in vitro of different stages of tissue parasites. International publication WO 94\/26899. 1994."},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0001-706X(95)00079-T","article-title":"A highly sensitive and rapid procedure for direct PCR detection of Leishmania infantum within human peripheral blood mononuclear cells","volume":"59","author":"Ravel","year":"1995","journal-title":"Acta Trop"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0304-4017(00)00312-5","article-title":"Infection of a canine macrophage cell line with leishmania infantum: determination of nitric oxide production and anti-leishmanial activity","volume":"92","author":"Pinelli","year":"2000","journal-title":"Vet Parasitol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.02.083_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/00034983.1994.11812879","article-title":"Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy","volume":"88","author":"Alvar","year":"1994","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.083_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1590\/S0074-02761994000200001","article-title":"Visceral leishmaniasis in Teresina, State of Piaui, Brazil: preliminary observations on the detection and transmissibility of canine and sandfly infections","volume":"89","author":"Vexenat","year":"1994","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.083_bib40","doi-asserted-by":"crossref","first-page":"912","DOI":"10.26719\/2001.7.6.912","article-title":"Seroepidemiological study of visceral leishmaniasis among humans and animal reservoirs in Bushehr province, Islamic Republic of Iran","volume":"7","author":"Mohebali","year":"2001","journal-title":"East Mediterr Health J"},{"issue":"Suppl","key":"10.1016\/j.vaccine.2007.02.083_bib41","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1017\/S0031182000072243","article-title":"Experiences with vaccines against cutaneous leishmaniasis: of men and mice","volume":"98","author":"Modabber","year":"1989","journal-title":"Parasitology"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2007.02.083_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/00034983.1995.11813017","article-title":"Vaccines against leishmaniasis","volume":"89","author":"Modabber","year":"1995","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.083_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/CMR.14.2.229-243.2001","article-title":"Leishmaniasis: current status of vaccine development","volume":"14","author":"Handman","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"6","key":"10.1016\/j.vaccine.2007.02.083_bib44","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2174\/1566524043360212","article-title":"Progress in vaccine research and possible effector mechanisms in visceral leishmaniasis","volume":"4","author":"Ravindran","year":"2004","journal-title":"Curr Mol Med"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2007.02.083_bib45","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/j.vaccine.2003.11.039","article-title":"Effective immunotherapy against canine visceral leishmaniasis with the FML-vaccine","volume":"22","author":"Borja-Cabrera","year":"2004","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.02.083_bib46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0264-410X(98)00220-5","article-title":"A randomised, double-blind, controlled trial of a killed L. major vaccine plus BCG against zoonotic cutaneous leishmaniasis in Iran","volume":"17","author":"Momeni","year":"1999","journal-title":"Vaccine"},{"issue":"9115","key":"10.1016\/j.vaccine.2007.02.083_bib47","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(98)09552-X","article-title":"Randomised vaccine trial of single dose of killed Leishmania major plus BCG against anthroponotic cutaneous leishmaniasis in Bam, Iran","volume":"351","author":"Sharifi","year":"1998","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2007.02.083_bib48","first-page":"468","article-title":"Safety and immunogenicity of an autoclaved Leishmania major vaccine","volume":"77","author":"Khalil","year":"2000","journal-title":"East Afr Med J"},{"issue":"20","key":"10.1016\/j.vaccine.2007.02.083_bib49","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0264-410X(98)00075-9","article-title":"Vaccination with recombinant Parasite Surface Antigen 2 from Leishmania major induces a Th1 type of immune response but does not protect against infection","volume":"16","author":"Sjolander","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.083_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4267\/2042\/47687","article-title":"Canine leishmaniosis due to Leishmania infantum:immunotherapy trials","volume":"157","author":"Bourdoiseau","year":"2004","journal-title":"Bull Acad Vet France"},{"issue":"1","key":"10.1016\/j.vaccine.2007.02.083_bib51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1128\/IAI.62.1.229-235.1994","article-title":"Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum","volume":"62","author":"Pinelli","year":"1994","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2007.02.083_bib52","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1365-3024.2002.00444.x","article-title":"Arginase I induction in macrophages, triggered by Th2-type cytokines, supports the growth of intracellular Leishmania parasites","volume":"24","author":"Iniesta","year":"2002","journal-title":"Parasite Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.02.083_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/00002030-199402000-00024","article-title":"Indirect xenodiagnosis of visceral leishmaniasis in 10 HIV-infected patients using colonized Phlebotomus perniciosus","volume":"8","author":"Molina","year":"1994","journal-title":"Aids"},{"issue":"9","key":"10.1016\/j.vaccine.2007.02.083_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-3024.1995.tb00914.x","article-title":"Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites","volume":"17","author":"Deplazes","year":"1995","journal-title":"Parasite Immunol"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2007.02.083_bib55","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/S0264-410X(03)00046-X","article-title":"IgG1\/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis","volume":"21","author":"de Oliveira Mendes","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2007.02.083_bib56","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0031182006000837","article-title":"Phenotypical characteristics, biochemical pathways, molecular targets and putative role of nitric oxide-mediated programmed cell death in Leishmania","volume":"132","author":"Holzmuller","year":"2006","journal-title":"Parasitology"},{"issue":"12","key":"10.1016\/j.vaccine.2007.02.083_bib57","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.4049\/jimmunol.165.12.7064","article-title":"Immunization with a recombinant stage-regulated surface protein from Leishmania donovani induces protection against visceral leishmaniasis","volume":"165","author":"Stager","year":"2000","journal-title":"J Immunol"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2007.02.083_bib58","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/icb.1993.64","article-title":"Interferon-gamma and interleukin-4 in human Leishmania donovani infections","volume":"71","author":"Kemp","year":"1993","journal-title":"Immunol Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07002848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T20:55:10Z","timestamp":1683752110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07002848"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":58,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0264410X07002848"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.02.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}